US Stem Cell Inc (USRM)

[GoldenMind]

$USRM published in Journal of Clinical MEDICAL RESEARCH THIS NOV 2017

http://www.jocmr.org/index.php/JOCMR/article/view/3187

Link to Trial here https://clinicaltrials.gov/ct2/show/NCT03226093?term=bioheart&rank=6
Enrollment: 676
Actual Study Start Date: January 1, 2015
Study Completion Date: June 1, 2017
Primary Completion Date: January 1, 2017 (Final data collection date for primary outcome measure)


& WOW talk about world wide acceptance for the use of the Stromal Vascular Fraction \/\/\/\/\/\/

http://markets.businessinsider.com/news/stocks/Tissue-Genesis-LLC-and-Human-Life-CORD-Japan-Inc-Announce-Exclusive-Agreement-to-Advance-Adult-Stem-Cell-Therapies-in-Asia-1006386674

USRM is in the same boat. Things are getting exciting.


Looking for another month of growth

ASSETS
$283k Jun 2016
$413k Sep 2016
$427k Dec 2016
$1385k Mar 2017
$1632k Jun 2017
$______ Sept 2017

Revenues
$678k Jun 2016
$729k Sep 2016
$964k Dec 2016
$1154k Mar 2017
$1386k Jun 2017 (Gross profit now $985k in Jun 2017 vs 443k last Jun 2016)
$______ Sept 2017

Cash and Cash Equivalents
$130k Jun 2016
$246k Sep 2016
$270k Dec 2016
$619k Mar 2017
$930k Jun 2017
$______Sept 2017